The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands
Adjuvant chemotherapy was associated with an improved 5-year survival in all subgroups. The role of adjuvant chemotherapy in the treatment of rectal cancer should be reconsidered in node-positive patients.
Authors
- D. D. E. Zimmerman (ORCID: https://orcid.org/0000-0002-0393-9350)
- Felice N. van Erning (ORCID: https://orcid.org/0000-0003-0125-1429)
- Marcel Verheij (ORCID: https://orcid.org/0000-0002-8079-7421)
- Pauline A. J. Vissers (ORCID: https://orcid.org/0000-0002-0677-888X)
- Tijmen Koëter (ORCID: https://orcid.org/0000-0002-1746-8684)
- Henk M.W. Verheul (ORCID: https://orcid.org/0000-0001-5981-922X)
- Johannes H. W. de Wilt
- Robbert J. van Alphen
- Aaya Darai (ORCID: https://orcid.org/0009-0000-6138-6398)
Institutions
- Radboud University Nijmegen (NL)
- Catharina Ziekenhuis (NL)
- Radboud University Medical Center (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Elisabeth-TweeSteden Ziekenhuis (NL)
Publication Details
- Journal
- Colorectal Disease
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/codi.70054
- Citations
- 2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.09